LINDSEY ATANASOV: Open Payments
NPI 1568176451 · WOOSTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 94 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $344 · 2025 $1,661
Food & beverage: $1,661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $703 |
| Ardelyx, Inc. | 11 | $211 |
| Janssen Biotech, Inc. | 7 | $181 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $147 |
| Lilly USA, LLC | 4 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Ascendis Pharma Endocrinology Inc | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
Products named: RINVOQ, SKYRIZI, IBSRELA, TREMFYA, XIFAXAN, LINZESS, OMVOH, VOQUEZNA.
Industry payments across OH — which companies pay providers there.
